Background. People living with HIV (PLHIV) are at a high‐risk of developing AIDS‐defining
cancers (ADCs) and non‐AIDS‐defining cancers (NADCs). This review is aimed at exploring …

Background Non-AIDS-defining cancers (NADCs) are now becoming a rising cause of
morbidity among people living with HIV (PLHIV) in the highly active antiretroviral therapy …

In the highly active antiretroviral therapy (HAART) era, the incidence of non-AIDS-defining
cancers (NADC) has increased and contributes to a growing proportion of mortality in the …

Objectives The aim of the study was to investigate the incidence of AIDS‐defining cancers
(ADCs) and virus‐related and non‐virus‐related non‐AIDS‐defining cancers (NADCs) in …

Monitoring cancer trends and risk is critical as cancer remains a growing problem in persons
living with HIV (PLWH). Recent population-based data are limited regarding the cancer …

With the advent of effective combination antiretroviral therapy, HIV infection has been
transformed from a fatal disease to a chronic condition. There is renewed clinical interest in …

Background The objective of this study is to evaluate the incidence of non-AIDS defining
malignancies (NADMs) among people living with HIV/AIDS (PLWHA) in British Columbia …

Simple Summary People living with HIV have an increased risk of developing cancer during
their lifetime. Thanks to the introduction and evolution of antiretroviral therapy, cancer …

Purpose of review The introduction of antiretroviral therapy (ART) has revolutionized HIV
infection management, resulting in improved outcomes and survival for people living with …

The advent of highly active antiretroviral therapy (HAART) has significantly reduced the
incidence of AIDS events, including AIDS-defining malignancies. Nevertheless, several …